Association of Atrial Nicotinamide Adenine Dinucleotide Phosphate Oxidase Activity with the Development of Atrial Fibrillation After Cardiac Surgery
Overview
Affiliations
Objectives: Our goal was to evaluate the role of myocardial nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity and plasma markers of oxidative stress in the pathogenesis of post-operative atrial fibrillation (AF).
Background: Atrial fibrillation is a common complication of cardiac surgery, leading to increased morbidity and prolonged hospitalization. Experimental evidence suggests that oxidative stress may be involved in the pathogenesis of AF; however, the relevance of this putative mechanism in patients undergoing cardiac surgery is unclear.
Methods: We measured basal and NADPH-stimulated superoxide production in right atrial appendage samples from 170 consecutive patients undergoing conventional coronary artery bypass surgery. Plasma markers of lipid and protein oxidation (thiorbabituric acid-reactive substances, 8-isoprostane, and protein carbonyls) were also measured in blood samples drawn from a central line before surgery and after reperfusion.
Results: Patients who developed AF after surgery (42%) were older and had a significantly increased atrial NADPH oxidase activity than patients who remained in sinus rhythm (SR) (in relative light units/s/mug protein: 4.78 +/- 1.44 vs. 3.53 +/- 1.04 in SR patients, p < 0.0001). Plasma markers of lipid and protein oxidation increased significantly after reperfusion; however, neither pre-operative nor post-operative measurements differed between patients who developed AF and those who remained in SR after surgery. Multivariate analysis identified atrial NADPH oxidase activity as the strongest independent predictor of post-operative AF (odds ratio 2.41; 95% confidence interval 1.71 to 3.40, p < 0.0001).
Conclusions: Atrial NADPH oxidase activity is independently associated with an increased risk of post-operative AF, suggesting that this oxidase system may be a key mediator of atrial oxidative stress leading to the development of AF after cardiac surgery.
Castillo R, Farias J, Sandoval C, Gonzalez-Candia A, Figueroa E, Quezada M Antioxidants (Basel). 2024; 13(11).
PMID: 39594530 PMC: 11591087. DOI: 10.3390/antiox13111388.
Salica A, Cammisotto V, Scaffa R, Folino G, De Paulis R, Carnevale R Antioxidants (Basel). 2024; 13(10).
PMID: 39456434 PMC: 11505158. DOI: 10.3390/antiox13101180.
Hanafy D, Willim H, Trianita Suwatri W, Sani A, Khouw H, Susanti E Rev Cardiovasc Med. 2024; 25(7):243.
PMID: 39139444 PMC: 11317354. DOI: 10.31083/j.rcm2507243.
Balan A, Halatiu V, Scridon A Antioxidants (Basel). 2024; 13(1).
PMID: 38247541 PMC: 10812976. DOI: 10.3390/antiox13010117.
Szyller J, Antoniak R, Wadowska K, Bil-Lula I, Hrymniak B, Banasiak W Front Physiol. 2023; 14:1289587.
PMID: 38028798 PMC: 10663344. DOI: 10.3389/fphys.2023.1289587.